ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering. There can be no …
In several ways, Acadia Pharmaceuticals (NASDAQ: ACAD) crushed it in 2017 ... Despite all of this good news, Acadia stock finished the year up only 4%. Acadia CEO Stephen Davis didn't mention the underwhelming performance of the …
NWI1mon
Investor confidence in a potential acquisition of Acadia Pharmaceuticals (NASDAQ: ACAD) seems to have waned, and …
Nuplazid is the first FDA-approved therapy for Parkinson's disease psychosis (PDP) and after deciding to retain the rights to the drug, ACADIA Pharmaceuticals launched it in May.The company raised $500 million this year via dilutive stock
The 2012 SandHills Stock Show & Rodeo Director Angie Bryant, President Bill Wight and Vice President Kevin Evans presented scholarships to the 2012 Miss Rodeo SandHills Ashley Buffington, Miss Rodeo SandHills Teen Carlie Porter …
ACADIA Pharmaceuticals Inc. ACAD is scheduled to report second-quarter 2016 results on Aug 4 after the market closes. In the last reported quarter, ACADIA had posted a negative earnings surprise of -12.5%. Let’s see how things are …
Coming into the season, McMillen had 172 career starts. Joining McMillen on the champion’s podium before another sold out house were Matt Hagan (Funny Car), Greg Anderson (Pro Stock) and Eddie Krawiec (Pro Stock Motorcycle). …